
What We're Reading: FDA and Medical Devices; CVS–Aetna Merger to Close; GAO Probe of Trump Associates
The FDA will revamp the process for approving most medical devices, which has long been criticized by experts for failing to catch problems with risky implants and related products; the $69 billion merger between CVS and Aetna is expected to close Wednesday after New York signed off on the deal; the Government Accountability Office (GAO) will investigate whether members of President Donald Trump’s private club in Florida improperly influenced the Department of Veterans Affairs.
Medical Device Approval Process to See Overhaul by FDA
The FDA will revamp the process for approving most medical devices, which has long been criticized by experts for failing to catch problems with risky implants and related products, a day after the publication of a global investigation into medical device safety by more than 50 media organizations.
CVS—Aetna Deal Set to Close
The $69 billion merger between CVS and Aetna is expected to close Wednesday after New York signed off on the deal Monday,
GAO to Probe Trump Associates for Undue Influence in VA EHR Contract
The Government Accountability Office (GAO) will investigate whether members of President Donald Trump’s private club in Florida improperly influenced the Department of Veterans Affairs (VA),
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.